University of Arkansas

Little Rock, Arkansas 72211

9 studies enrolling now · 54 studies all time

What they study most

Acute Liver Failure, Alzheimer's Disease, Apathy, Arm Paralysis, Aspergillosis, Atherosclerosis, Atrial Septal Defect Secundum, B Cell Lymphoma, B Cell Non-Hodgkin's Lymphoma, Biliary Cirrhosis, Primary, Breast Reconstruction, Carcinoma, Squamous Cell

Studies at this site

• Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors — Recruiting now
• A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy — Recruiting now
• A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer — Recruiting now
• A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease — Recruiting now
• Belimumab With Rituximab for Primary Membranous Nephropathy — Recruiting now
• The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry — Recruiting now
• Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients — Recruiting now
• Acellular Dermal Matrix Investigation in Breast Reconstruction — Recruiting now
• Smart Checklist Implementation for Pediatric Tracheal Intubations in the ICU- Multicenter Study — Recruiting now
• Optimizing the Use of Ketamine to Reduce Chronic Postsurgical Pain — Running, not enrolling
• Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD — Running, not enrolling
• Preterm Erythropoietin Neuroprotection Trial (PENUT Trial) — Completed
• A Longitudinal Observational Study of the Natural History and Management of Patients With HCC — Running, not enrolling
• A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme — Running, not enrolling
• A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma — Running, not enrolling
• A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis — Completed
• CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER) — Status unconfirmed
• Pilot Study of Crenolanib Combined With Standard Salvage Chemotherapy in Subjects With R/R AML — Completed
• Apathy in Dementia Methylphenidate Trial 2 — Completed
• Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19) — Completed
• A Dose Ranging Study Evaluating Efficacy and Safety of NI-03 — Completed
• FLASH [Fluorescent Light Activated Synthetic Hypericin] Clinical Study: Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides) — Completed
• The Development and Evaluation of a Novel Duodenoscope Assessment Tool — Completed
• Endoscopic Suturing (ES) Registry — Completed
• Predicting the Safety and Effectiveness of Inferior Vena Cava Filters — Completed
• Investigation of Neural Stem Cells in Ischemic Stroke — Stopped early
• Emergency Use of OCR-002 in Acute Liver Failure (ALF) — NO_LONGER_AVAILABLE
• A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM) — Completed
• Program to Reduce Incontinence by Diet and Exercise — Completed
• PK Study With Pantoprazole in Obese Children and Adolescents — Completed
• A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial — Completed
• ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study — Stopped early
• Racial Difference in HCV/Host Interactions — Completed
• Treatment of Egg Allergy in Children Through Oral Desensitization (EGG OIT) — Completed
• Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia — Completed
• Characterization of Childhood-Onset Obsessive-Compulsive Disorder — Completed
• Enteral Formula Tolerance of Standard Tube Feedings — Completed
• Depsipeptide to Treat Patients With Cutaneous T-Cell Lymphoma and Peripheral T-Cell Lymphoma — Completed
• Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary Bypass — Completed
• Niacin Plus Statin to Prevent Vascular Events — Stopped early
• Prophylactic Phenobarbital After Neonatal Seizures — Stopped early
• Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer — Stopped early
• Multi-center Assessment of Grafts in Coronaries: Long-term Evaluation of the C-Port Device — Completed
• Trial of Combination Antifungal Therapy (Vori+Mica vs. Vori+Placebo) in Invasive Aspergillosis — Withdrawn before enrolling
• A Carotid Stenting Boston Scientific Surveillance Program — Completed
• A Multiple Myeloma Trial in Patients With Bone Metastases — Completed
• IVIG - West Nile Encephalitis: Safety and Efficacy — Completed
• Valganciclovir in Congenital CMV Infants — Completed
• Spectroscopic Evaluation of Cervical Neoplasia — Completed
• Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy Alone — Status unconfirmed